Discovery of the Antiulcer Drug Tagamet

Drug Discovery and Development

Volumn 1, Issue , 2006, Pages 295-311

  Ganellin, C Robin ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antiulcer drug Tagamet; Developing clinical candidate drug; H2 receptor histamine antagonist

Indexed keywords

EID: 69649090844     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0471780103.ch10     Document Type: Chapter

References (25)

1. Ash, A. S. E, and H. O. Schild (1966), Br. J. Pharmacol. Chemother. 27, 427-439.
2. Black, J. W., W. A. M. Duncan, G. J. Durant, C. R. Ganellin, and M. E. Parsons (1972), Nature, 236:385-390.
3. Black, J. W., G. J. Durant, J. C. Emmett, and C. R. Ganellin (1974), Nature, 248:65-67.
4. Bovet, D. (1950), Ann. N. Y. Acad. Sei. 50, Art., 9:1089-1126.
5. Bradshaw, J., M. E. Butcher, J. W. Clitherow, M. D. Dowle, R. Hayes, D. B. Judd, J. M. McKinnon, and B. J. Price (1982), in A. M. Creighton and S. Turner, eds., Chemical Regulation of Biological Mechanisms, Special Publication 42, Royal Society of Chemistry, London, pp. 45-57.
6. Brimblecombe, R. W., W. A. M. Duncan, G. J. Durant, J. C. Emmett, C. R. Ganellin, and M. E. Parsons (1975), J. Int. Med. Res., 3:86-92.
7. Brimblecombe, R. W., W. A. M. Duncan, G. J. Durant, J. C. Emmett, C. R. Ganellin, G. B. Leslie, and M. E. Parsons (1978), Gastroenterology, 74:339-347.
8. Charton, M. (1965a), J. Org. Chem. 30, 3346-3350.
9. Charton, M. (1965b), J. Org. Chem. 30, 969-973.
10. Dale, H. H., and P. P. Laidlaw (1910), J. Physiol. (London),, 41:318-344.
11. Durant, G. J., J. C. Emmett, C. R. Ganellin, P. D. Miles, H. D. Prain, M. E. Parsons, and G. R. White (1977), J. Med. Chem., 20:901-906.
12. Folkow, B., K. Haeger, and G. Kahlson (1948), Acta Physiol. Seand., 15:264-278.
13. Freston, J. W. (1982), Ann. Intern. Med., 97:573-580.
14. Ganellin, C. R. (1981), J. Med. Chem., 24:913-920.
15. Ganellin, C. R., G. J. Durant, and J. C. Emmett (1976), Fed. Proc. Fed. Am. Soc. Exp. Biol., 35:1924-1930.
16. Ghosh, M. M., and H. O. Schild (1958), Br. J. Pharmacol. Chemother., 13:54-61.
17. Gregory, H., R. C. Sheppard, D. S. Jones, P. M. Hardy and G. W. Kenner (1964), Nature (London), 204:931-933.
18. Gregory, R. A., and H. J. Tracy (1961), J. Physiol. (London), 156:523-543.
19. Grossman, M. I., C. Robertson, and C. E. Rosiere (1952), J. Pharmacol. Exp. Ther., 104:277-283.
20. Johnson, L. R. (1971), Gastroenterology, 61:106-118.
21. Lin, T. M., R. S. Alphin, F. G. Henderson, D. N. Benslay, and K. K. Chen (1962), Ann. N. Y. Acad. Sci., 99:30-44.
22. Lin, T. M., D. C. Evans, M. W. Warrick, R. P. Pioch, and R. R. Ruffalo (1983), Gastroenterology 84, 1231.
23. Takeda, M., T. Tagaki, Y. Yashima, and H. Maeno (1982), Arzneim. Forsch. 32(ii), 734-737.
24. Van den Brink, F. G. (1969), in Histamine and Antihistamines, Molecular Pharmacology, Structure-Activity Relations, Gastric Acid Secretion, Drukkerij Gebr. Janssen, Nijmegen, The Netherlands, p. 179.
25. Winship, D. H. (1978), Gastroenterology 74, 402-406